YYÜ GCRIS Basic veritabanının içerik oluşturulması ve kurulumu Research Ecosystems (https://www.researchecosystems.com) tarafından devam etmektedir. Bu süreçte gördüğünüz verilerde eksikler olabilir.
 

Development of an Ion-Pair Hplc Method for Determination of Acebutolol in Pharmaceuticals

dc.authorid Senturk, Zuhre/0000-0002-0356-9345
dc.authorid Levent, Abdulkadir/0000-0001-5792-419X
dc.authorscopusid 6602133530
dc.authorscopusid 7004177719
dc.authorwosid Senturk, Zuhre/Aas-5179-2020
dc.authorwosid Levent, Abdulkadir/V-5418-2017
dc.contributor.author Levent, Abdulkadir
dc.contributor.author Senturk, Zuehre
dc.date.accessioned 2025-05-10T17:19:35Z
dc.date.available 2025-05-10T17:19:35Z
dc.date.issued 2010
dc.department T.C. Van Yüzüncü Yıl Üniversitesi en_US
dc.department-temp [Levent, Abdulkadir; Senturk, Zuehre] Yuzuncu Yil Univ, Dept Analyt Chem, Fac Sci & Art, TR-65080 Van, Turkey en_US
dc.description Senturk, Zuhre/0000-0002-0356-9345; Levent, Abdulkadir/0000-0001-5792-419X en_US
dc.description.abstract A simple and accurate ion-pair reversed-phase high-performance liquid chromatographic (RP-HPLC) method has been developed and validated for determination of acebutolol (ACE) in tablet dosage forms. Both ACE and ambroxol (internal standard) were well separated using a reversed phase column and a mobile phase consisting of a mixture of methanol-0.05 M acetic acid (containing 8 mM sodium 1-heptanesulfanate) (65:35 v/v) with pH adjusted to 3.2 with triethylamine. The mobile phase was pumped at 0.80 mLmin(-1) flow rate and ACE was detected by diode-array detection at 240 nm. The retention times for ACE and internal standard (IS) were 4.574 and 8.236 min, respectively. A linear response (r = 0.9998) was observed in the range of 0.27-2.93 mu g mL(-1) in mobile phase. The limit of detection and limit of quantification were found as 0.07 and 0.23 mu g mL(-1) in the mobile phase. Validation parameters such as precision, accuracy, selectivity, reproducibility, and system suitability tests were also determined. The excipients did not interfere with the assay of ACE in tablet dosage forms. It is suggested that the proposed method can be used for routine quality control and dosage-form assay of ACE. en_US
dc.description.woscitationindex Science Citation Index Expanded
dc.identifier.doi 10.1080/00032710903502116
dc.identifier.endpage 1456 en_US
dc.identifier.issn 0003-2719
dc.identifier.issue 9 en_US
dc.identifier.scopus 2-s2.0-77953658737
dc.identifier.scopusquality Q3
dc.identifier.startpage 1448 en_US
dc.identifier.uri https://doi.org/10.1080/00032710903502116
dc.identifier.uri https://hdl.handle.net/20.500.14720/9848
dc.identifier.volume 43 en_US
dc.identifier.wos WOS:000278775700003
dc.identifier.wosquality Q3
dc.language.iso en en_US
dc.publisher Taylor & Francis inc en_US
dc.relation.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
dc.rights info:eu-repo/semantics/closedAccess en_US
dc.subject Acebutolol en_US
dc.subject Ion-Pair en_US
dc.subject Rp-Hplc en_US
dc.title Development of an Ion-Pair Hplc Method for Determination of Acebutolol in Pharmaceuticals en_US
dc.type Article en_US

Files